Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 54Neoplasms 38Lung Neoplasms 25Colorectal Neoplasms 24Prostatic Neoplasms 17Uterine Cervical Neoplasms 14Motor Activity 13Colonic Neoplasms 11Pancreatic Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Rectal Neoplasms 9Hematologic Neoplasms 9Anxiety Disorders 9Urinary Bladder Neoplasms 8Obesity 8Melanoma 8Lymphoma 8Depression 8Ovarian Neoplasms 7Endometrial Neoplasms 7Vulvar Neoplasms 6Neoplasm Metastasis 6Head and Neck Neoplasms 6Breast Carcinoma In Situ 6Sarcoma 5Papillomavirus Infections 5Pain 5Leukemia, Myeloid, Acute 5Hematopoietic and Lymphatic System Neoplasm 5Triple Negative Breast Neoplasms 4

Interventions

bisaramil 1Varenicline 1Tobacco Use Cessation Devices 1Surveys and Questionnaires 1Nicotine Chewing Gum 1Moclobemide 1Methods 1Escitalopram 1Early Intervention, Educational 1Bupropion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Behavior, Addictive × Methods × Clear all
NCT06945120 2026-03-13

ACT Lung Health Intervention: Phase Two

Dana-Farber Cancer Institute

Phase NA Recruiting
50 enrolled

Cigarette Smoking, Tobacco Smoking, Smoking, Smoking Cessation, Behavior, Addictive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡